Rapid Micro Biosystems (RPID) Cash from Financing Activities (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Cash from Financing Activities of $247000.0 in Q1 2026, down 44.24% quarter-over-quarter from $443000.0 in Q4 2025, and down 34.83% year-over-year from $379000.0 in Q1 2025.
Rapid Micro Biosystems' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $247000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 34.83% year-over-year to $247000.0; the TTM figure through Mar 2026 stood at $19.6 million (up 4531.84% YoY), while the FY2025 annual figure was $19.8 million, up 9639.41% from the prior year.
- Cash from Financing Activities came in at $247000.0 for Q1 2026 at Rapid Micro Biosystems, down from $443000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $19.2 million in Q3 2025 to a low of -$298000.0 in Q2 2025.
- A 5-year average of $1.2 million and a median of $87000.0 in 2022 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 31452.46% in 2025 and fell as far as 2880.0% in 2025.
- Rapid Micro Biosystems' Cash from Financing Activities stood at $87000.0 in 2022, then sank by 113.79% to -$12000.0 in 2023, then soared by 50.0% to -$6000.0 in 2024, then jumped by 7483.33% to $443000.0 in 2025, then sank by 44.24% to $247000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $247000.0, $443000.0, and $19.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 247,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Sep 30, 2025 | 19.25 Mn |
| Sep 30, 2025 | 19.25 Mn |
| Jun 30, 2025 | -298,000.00 |
| Jun 30, 2025 | -298,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Jun 30, 2022 | -8,000.00 |
| Jun 30, 2022 | -8,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Dec 31, 2021 | -1.26 Mn |
| Dec 31, 2021 | -1.26 Mn |
| Sep 30, 2021 | 139.31 Mn |
| Sep 30, 2021 | 139.31 Mn |
| Jun 30, 2021 | -1.38 Mn |
| Jun 30, 2021 | -1.38 Mn |
| Mar 31, 2021 | 80.07 Mn |
| Mar 31, 2021 | 80.07 Mn |
| Dec 31, 2020 | 49,000.00 |
| Dec 31, 2020 | 49,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Sep 30, 2020 | 5,000.00 |